TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 May 2014

Transcription

1 30 May 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012 and 2013/14 Invitation to Tender, dated 07 November Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted. Notification of Product Changes (NOPC) forms and Pharmacodes Please note that for any changes ( change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12 th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website Where a product does not have a current Pharmacode, suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand before the 12 th of the month prior to the date of listing. PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode. A Page 1 of 17

2 2012/13 Tender Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2016 Community pharmaceutical tenders Section B of the Pharmaceutical Schedule 1. Tenders awarded to currently listed pharmaceuticals where no other brand is listed. The decisions were as follows: Chemical name subsidy and () New subsidy and Date of subsidy change Sole Subsidised Supply date Tranexamic acid tab 500 mg; 100, bottle pack $32.92 $23.00 Cyklokapron (Pfizer) 1 August November 2014 Hospital pharmaceutical tenders Section H of the Pharmaceutical Schedule 2. Tenders awarded to listed pharmaceuticals where only the current brand is listed. The decisions were as follows: Chemical Name pack New pack Hospital Supply DV Limit Date of change Hospital Supply Status date Tranexamic acid tab 500 mg; 100, bottle pack $32.92 $23.00 Cyklokapron (Pfizer) 1% 1 August October 2014 A Page 2 of 17

3 2013/14 Tender Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2017 Community pharmaceutical tenders Section B of the Pharmaceutical Schedule 3. Tenders awarded to pharmaceuticals where at least one other brand or pack size is listed. The decisions were as follows: Chemical Name subsidy and () New subsidy and Date of listing/subsidy Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) affected by reference pricing and delisting Amitriptyline 1 tab 25 mg; 100, blister pack $1.85 $1.68 Arrow-Amitriptyline 1 October December March 2015 Amitrip Amitriptyline 1 tab 50 mg; 100, blister pack $3.60 $2.82 Arrow-Amitriptyline 1 October December March 2015 Amitrip Amorolfine nail soln 5%; 5 ml OP, bottle pack $37.86 ($61.87) $19.95 MycoNail (AFT) 1 November January April 2015 Loceryl (Healthcare Logistics) Imiquimod crm 5%, 250 mg sachet; 12 sachets $62.00 $17.98 Apo-Imiquimod Cream 5% 1 December February May 2015 Aldara (Valeant) Octreotide inj 50 mcg per ml, 1 ml vial; 5 vials $19.24 $13.50 DBL Octreotide MaxRx (Max Health) Octreotide inj 100 mcg per ml, 1 ml vial; 5 vials $36.38 $22.40 DBL Octreotide MaxRx (Max Health) Octreotide inj 500 mcg per ml, 1 ml vial; 5 vials $ $89.40 DBL Octreotide MaxRx (Max Health) A qa25123 Page 3 of 17

4 Chemical Name subsidy and () New subsidy and Date of listing/subsidy Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) affected by reference pricing and delisting Olanzine-D + Olanzapine 2 tab orodispersible 5 mg; 28, blister pack $6.36 $1.75 Zypine ODT Dr Reddy s Olanzapine Zyprexa Zydis (Eli Lilly) Olanzine-D + Olanzapine 2 tab orodispersible 10 mg; 28, blister pack $8.76 $3.05 Zypine ODT Dr Reddy s Olanzapine Zyprexa Zydis (Eli Lilly) + Olanzapine 2 tab 2.5 mg; 28, blister pack $2.00 $0.75 Zypine Dr Reddy s Olanzapine Zyprexa (Eli Lilly) Olanzine + Olanzapine 2 tab 5 mg; 28, blister pack $3.85 $1.65 Zypine Dr Reddy s Olanzapine Zyprexa (Eli Lilly) Olanzine + Olanzapine 2 tab 10 mg; 28, blister pack $6.35 $2.55 Zypine Dr Reddy s Olanzapine Zyprexa (Eli Lilly) A qa25123 Page 4 of 17

5 Chemical Name subsidy and () New subsidy and Date of listing/subsidy Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) affected by reference pricing and delisting Paracetamol with codeine tab paracetamol 500 mg with codeine phosphate 8 mg; 1,000, blister pack $2.70 per 100 s $21.06 per 1,000 s Paracetamol + Codeine (Relieve) 1 October December March 2015 Paracetamol + Codeine (Relieve) packsize Dr Reddy s Quetiapine + Quetiapine 2 tab 25 mg; 90, blister pack $10.50 per 90 s $2.10 per 90 s Quetapel Seroquel Dr Reddy s Quetiapine + Quetiapine 2 tab 100 mg; 90, blister pack $21.00 per 90 s $4.20 per 90 s Quetapel Seroquel Dr Reddy s Quetiapine + Quetiapine 2 tab 200 mg; 90, blister pack $36.00 per 90 s $7.20 per 90 s Quetapel Seroquel Dr Reddy s Quetiapine + Quetiapine 2 tab 300 mg; 90, blister pack $60.00 per 90 s $12.00 per 90 s Quetapel Seroquel + 2 oral liq1 mg per ml; 30 ml, bottle pack $18.35 $9.75 Risperon A qa25123 Page 5 of 17

6 Chemical Name subsidy and () New subsidy and Date of listing/subsidy Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) affected by reference pricing and delisting + 3 tab 0.5 mg; 60, blister pack $3.51 per 60 $1.90 per 60 1 October February May tab 1 mg; 60, blister pack $6.00 per 60 $2.10 per 60 1 October February May tab 2 mg; 60, blister pack $11.00 per 60 $2.34 per 60 1 October February May 2015 A qa25123 Page 6 of 17

7 Chemical Name subsidy and () New subsidy and Date of listing/subsidy Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) affected by reference pricing and delisting + 3 tab 3 mg; 60, blister pack $15.00 per 60 $2.55 per 60 1 October February May tab 4 mg; 60, blister pack $20.00 per 60 $3.50 per 60 1 October February May We will be providing more information about the antipsychotic changes for clinicians, consumers, pharmacies and caregivers over the coming months 1. A Brand Switch Fee of $4.33 is payable for this product from 1 March 2015 until 1 June A Brand Switch Fee of $4.33 is payable for this product from 1 December 2014 until 1 March A Brand Switch Fee of $4.33 is payable for this product from 1 May 2015 until 1 August Tenders awarded to currently listed pharmaceuticals where no other brand is listed. The decisions were as follows: Chemical name subsidy and () New subsidy and Date of subsidy change Sole Subsidised Supply date Amitriptyline tab 10 mg; 100, blister pack $3.32 $1.68 Arrow-Amitriptyline A qa25123 Page 7 of 17

8 Chemical name subsidy and () New subsidy and Date of subsidy change Sole Subsidised Supply date Calcium carbonate tab 1.25 g (500 mg elemental); 250, bottle pack $6.38 $5.38 Arrow-Calcium Fluconazole cap 50 mg; 28 capsule, blister pack $4.77 $3.49 Ozole 1 September December 2014 Fluconazole cap 150 mg; 1 capsule, blister pack $0.91 $0.71 Ozole 1 September December 2014 Fluconazole cap 200 mg; 28 capsule, blister pack $13.34 $9.69 Ozole 1 September December 2014 Ipratropium bromide aqueous nasal spray, 0.03%; 15 ml, vial $4.03 $3.95 Univent (Rex Medical) 1 November February 2015 Lidocaine [lignocaine] oral (viscous) soln 2%; 200 ml, bottle pack $55.00 $55.00 Xylocaine Viscous Pethidine inj 50 mg per ml, 1 ml; 5 ampoules $5.51 $5.51 DBL Pethidine Hydrochloride Pethidine inj 50 mg per ml, 2 ml; 5 ampoules $5.83 $5.83 DBL Pethidine Hydrochloride Simvastatin tab 10 mg; 90, blister pack $1.40 $0.95 Arrow-Simva 10mg Simvastatin tab 20 mg; 90, blister pack $1.95 $1.61 Arrow-Simva 20mg Simvastatin tab 40 mg; 90, blister pack $3.18 $2.83 Arrow-Simva 40mg Simvastatin tab 80 mg; 90, blister pack $9.31 $7.91 Arrow-Simva 80mg A qa25123 Page 8 of 17

9 5. Tenders awarded to pharmaceuticals where no brand is listed. The decisions were as follows: Chemical Name Pack Listing date Sole Subsidised Supply date Granisetron * tab 1 mg; 50, blister pack $5.98 Granirex (Rex Medical) 1 November February 2015 *Stat dispensing will apply to this product A qa25123 Page 9 of 17

10 Hospital pharmaceutical tenders Section H of the Pharmaceutical Schedule 6. Tenders awarded to pharmaceuticals where at least one other brand or pack size is listed. The decisions were as follows: Chemical Name pack New pack Hospital Supply DV Limit Date of listing/ Hospital Supply Status date (and delisting of other listed brands) to be delisted Amitriptyline tab 25 mg; 100, blister pack $1.85 $1.68 Arrow-Amitriptyline 1% 1 October December 2014 Amitrip Amitriptyline tab 50 mg; 100, blister pack $3.60 $2.82 Arrow-Amitriptyline 1% 1 October December 2014 Amitrip *Amorolfine nail soln 5%; 5 ml, bottle pack $37.86 $19.95 MycoNail (AFT) 1% 1 November January 2015 Loceryl (Healthcare Logistics) Imiquimod crm 5%, 250 mg sachet; 12 sachets $62.00 $17.98 Apo-Imiquimod Cream 5% 1% 1 December February 2015 Aldara (Valeant) Octreotide inj 50 mcg per ml, 1 ml vial; 5 vials $19.24 $13.50 DBL Octreotide MaxRx (Max Health) Octreotide inj 100 mcg per ml, 1 ml vial; 5 vials $36.38 $22.40 DBL Octreotide MaxRx (Max Health) Octreotide inj 500 mcg per ml, 1 ml vial; 5 vials $ $89.40 DBL Octreotide MaxRx (Max Health) + Olanzapine tab orodispersible 5 mg; 28, blister pack $6.36 $1.75 Zypine ODT Olanzine-D + Olanzapine tab orodispersible 10 mg; 28, blister pack $8.76 $3.05 Zypine ODT Olanzine-D + Olanzapine tab 2.5 mg; 28, blister pack $2.00 $0.75 Zypine Olanzine + Olanzapine tab 5 mg; 28, blister pack $3.85 $1.65 Zypine Olanzine + Olanzapine tab 10 mg; 28, blister pack $6.35 $2.55 Zypine Olanzine A qa25123 Page 10 of 17

11 Chemical Name pack New pack Hospital Supply DV Limit Date of listing/ Hospital Supply Status date (and delisting of other listed brands) to be delisted Paclitaxel 1 inj 6 mg per ml, 16.7 ml vial; 1 vial $91.67 $19.02 Paclitaxel Ebewe (Sandoz) Paclitaxel Actavis Paclitaxel 1 inj 6 mg per ml, 25 ml vial; 1 vial $ $26.69 Paclitaxel Ebewe (Sandoz) Paclitaxel Actavis Anzatax Paclitaxel 1 inj 6 mg per ml, 50 ml via; 1 vial $ $36.53 Paclitaxel Ebewe (Sandoz) Paclitaxel Actavis Anzatax Dr Reddy s Quetiapine + Quetiapine tab 25 mg; 90, blister pack $10.50 per 90 s $2.10 per 90 s Quetapel Seroquel Dr Reddy s Quetiapine + Quetiapine tab 100 mg; 90, blister pack $21.00 per 90 s $4.20 per 90 s Quetapel Seroquel Dr Reddy s Quetiapine + Quetiapine tab 200 mg; 90, blister pack $36.00 per 90 s $7.20 per 90 s Quetapel Seroquel A qa25123 Page 11 of 17

12 Chemical Name pack New pack Hospital Supply DV Limit Date of listing/ Hospital Supply Status date (and delisting of other listed brands) to be delisted + Quetiapine tab 300 mg; 90, blister pack $60.00 per 90 s $12.00 per 90 s Quetapel Dr Reddy s Quetiapine Seroquel + oral liq1 mg per ml; 30 ml, bottle pack $18.35 $9.75 Risperon + tab 0.5 mg; 60, blister pack $3.51 per 60 $1.90 per 60 1% 1 October February tab 1 mg; 60, blister pack $6.00 per 60 $2.10 per 60 1% 1 October February 2015 A qa25123 Page 12 of 17

13 Chemical Name pack New pack Hospital Supply DV Limit Date of listing/ Hospital Supply Status date (and delisting of other listed brands) to be delisted + tab 2 mg; 60, blister pack $11.00 per 60 $2.34 per 60 1% 1 October February tab 3 mg; 60, blister pack $15.00 per 60 $2.55 per 60 1% 1 October February tab 4 mg; 60, blister pack $20.00 per 60 $3.50 per 60 1% 1 October February 2015 *Restrictions which currently apply for this product will be removed from 1 Novemeber We will be providing more information about the antipsychotic changes for clinicians, consumers, pharmacies and caregivers over the coming months 1. The and subsidy of paclitaxel (PCT Retail Pharmacy Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above s from 1 July The subsidy for paclitaxel inj 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $1.02 per 1 mg to $0.17 per 1 mg from 1 July 2014 A qa25123 Page 13 of 17

14 7. Tenders awarded to listed pharmaceuticals where only the current brand is listed. The decisions were as follows: Chemical Name pack New pack Hospital Supply DV Limit Date of change Hospital Supply Status date Amitriptyline tab 10 mg; 100, blister pack $3.32 $1.68 Arrow-Amitriptyline Calcium carbonate tab 1.25 g (500 mg elemental); 250, bottle pack $6.38 $5.38 Arrow-Calcium Fluconazole cap 50 mg; 28 capsule, blister pack $4.77 $3.49 Ozole 1% 1 September November 2014 Fluconazole cap 150 mg; 1 capsule, blister pack $0.91 $0.71 Ozole 1% 1 September November 2014 Fluconazole cap 200 mg; 28 capsule, blister pack $13.34 $9.69 Ozole 1% 1 September November 2014 Lidocaine [lignocaine] oral (viscous) soln 2%; 200 ml, bottle pack $55.00 $55.00 Xylocaine Viscous Paclitaxel 1 inj 6 mg per ml, 5 ml vial; 5 vials $ $45.00 Paclitaxel Ebewe (Sandoz) Paclitaxel 1 inj 6 mg per ml, 100 ml vial; 1 vial $ $73.06 Paclitaxel Ebewe (Sandoz) Pethidine inj 50 mg per ml, 1 ml; 5 ampoules $5.51 $5.51 DBL Pethidine Hydrochloride Pethidine inj 50 mg per ml, 2 ml; 5 ampoules $5.83 $5.83 DBL Pethidine Hydrochloride Simvastatin tab 10 mg; 90, blister pack $1.40 $0.95 Arrow-Simva 10mg Simvastatin tab 20 mg; 90, blister pack $1.95 $1.61 Arrow-Simva 20mg Simvastatin tab 40 mg; 90, blister pack $3.18 $2.83 Arrow-Simva 40mg A qa25123 Page 14 of 17

15 Simvastatin tab 80 mg; 90, blister pack $9.31 $7.91 Arrow-Simva 80mg 1. The and subsidy of paclitaxel (PCT Retail Pharmacy Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above s from 1 July The subsidy for paclitaxelinj 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $1.02 per 1 mg to $0.17 per 1 mg from 1 July Tenders awarded to pharmaceuticals where no brand is listed. The decisions were as follows: Chemical Name Pack Hospital Supply DV Limit Listing date Hospital Supply Status date Alfentanil inj 0.5 mg per ml, 2 ml ampoule; 10 ampoules $39.07 Hameln (Max Health) 1% 1 November January 2015 Atovaquone with proguanil tab 62.5 mg with proguanil 25 mg; 12 $25.00 Malarone Junior (GSK) 1% 1 September November 2014 Atovaquone with proguanil tab 250 mg with proguanil 100 mg; 12 $64.00 Malarone (GSK) 1% 1 September November 2014 Granisetron tab 1 mg; 50, blister pack $5.98 Granirex (Rex Medical) 1% 1 November January 2015 Ipratropium bromide aqueous nasal spray, 0.03%; 15 ml, vial $3.95 Univent (Rex Medical) 1% 1 November January 2015 Ketamine inj 1 mg per ml, 100 ml bag $27.00 Ketamine inj 4 mg per ml, 50 ml syringe $25.00 Ketamine inj 10 mg per ml, 10 ml syringe $14.00 Biomed (Biomed) Biomed (Biomed) Biomed (Biomed) A qa25123 Page 15 of 17

16 Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2012/13 Invitation to Tender, dated 31 October 2012 and 2013/14 Invitation to Tender, dated 07 November 2013: 2013/14 Invitation to Tender Chemical Name Line Item Chemical Name Line Item Isosorbide mononitrate Tab long-acting 60 mg Fentanyl inj 20 mcg per ml, 50 ml prefilled syringe Bupivacaine with fentanyl Bupivacaine with fentanyl Bupivacaine with fentanyl Bupivacaine with fentanyl Bupivacaine with fentanyl Bupivacaine with fentanyl Bupivacaine with fentanyl Calcium carbonate Fentanyl Fentanyl Inj mg with fentanyl 2 mcg per ml, 100 ml bag Inj 1.25mg with 2 mcg fentanyl per ml, 15 ml syringe Inj 1.25mg with 2 mcg fentanyl per ml, 20 ml syringe Inj 1.25 mg with fentanyl 2 mcg per ml, 50 ml syringe Inj 1.25 mg with fentanyl 2 mcg per ml, 100 ml syringe Inj 1.25mg with 2 mcg fentanyl per ml, 100 ml bag Inj 1.25mg with 2 mcg fentanyl per ml, 200 ml bag tab eff g (0.5 g - 1 g elemental) inj 10 mcg per ml, 10 ml syringe inj 10 mcg per ml, 50 ml prefilled syringe Fentanyl Fentanyl Fentanyl Granisetron Hyoscine N-butylbromide Lidocaine [lignocaine] Octreotide (somatostatin analogue) Octreotide (somatostatin analogue) Octreotide (somatostatin analogue) Quetiapine inj 10 mcg per ml, 50 ml premixed bag inj 10 mcg per ml, 100 ml premixed bag inj 20 mcg per ml, 100 ml bag Tab 2 mg Inj 20 mg, 1 ml Oral [viscous] soln 4% LAR inj 10 mg LAR inj 20 mg LAR inj 30 mg Tab 12.5 mg PHARMAC has resolved not to award tenders for Hospital Supply Status for the following products listed in the 2013/14 Invitation to Tender, dated 07 November 2013: Chemical Name Paracetamol with codeine Line Item tab paracetamol 500 mg with codeine phosphate 8 mg A qa25123 Page 16 of 17

17 For products included in the 2011/12 Invitation to Tender, 2012/13 or the 2013/14 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made. If you have any queries regarding this notification please contact PHARMAC on A qa25123 Page 17 of 17